Category: Include on Menu
-
AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance
AdaptHealth Corp. (NASDAQ:AHCO) shares plunged nearly 13% in pre-market trading after the home medical equipment provider reported second-quarter 2026 results that fell short of Wall Street expectations and sharply reduced its financial outlook for the year. The weaker-than-expected performance was accompanied by lower guidance for revenue, adjusted EBITDA and free cash flow. Earnings and Revenue…
-
Timken Tops Second-Quarter Expectations and Raises Full-Year Outlook
The Timken Company (NYSE:TKR) reported second-quarter 2026 results that exceeded Wall Street expectations, driven by stronger revenue, higher earnings and improving demand across its businesses. The industrial motion technology company’s shares rose 0.88% in pre-market trading following the earnings announcement. Earnings and Revenue Beat Forecasts Timken posted adjusted earnings of $1.83 per share for the…
-
Wayfair Shares Decline Despite Better-Than-Expected Second-Quarter Results
Wayfair (NYSE:W) shares fell around 3% in pre-market trading on Tuesday, even after the online home furnishings retailer reported second-quarter 2026 earnings and revenue that both exceeded Wall Street expectations. The company delivered solid sales growth, higher customer spending and continued gains in order volumes, but investors remained cautious following the results. Revenue and Earnings…
-
Toyota Beats First-Quarter Expectations as Hybrid Demand Drives Revenue Growth
Toyota Motor Corporation (NYSE:TM) reported first-quarter 2027 results that exceeded Wall Street expectations, supported by strong hybrid vehicle sales and higher revenue. The Japanese automaker also raised its full-year operating income and revenue forecasts, while its shares edged 0.28% higher in pre-market trading following the earnings release. Earnings and Revenue Top Forecasts Toyota posted adjusted…
-
Pfizer Raises Revenue Outlook as Eliquis Sales Drive Strong Quarter
Pfizer (NYSE:PFE) increased the lower end of its full-year revenue guidance after reporting second-quarter 2026 results that exceeded Wall Street expectations, supported by robust sales of its blood thinner Eliquis. The pharmaceutical company also reaffirmed its earnings outlook for the year, while its shares moved higher in U.S. pre-market trading following the announcement. Revenue and…
-
McDonald’s Beats Earnings Forecasts Despite Slight Revenue Miss
McDonald’s Corporation (NYSE:MCD) reported second-quarter 2026 results that exceeded Wall Street earnings expectations, although revenue came in slightly below analyst forecasts. The fast-food giant delivered higher profit and positive comparable sales growth across all of its operating segments, helping lift the stock 2.6% in pre-market trading. Earnings Top Expectations McDonald’s posted adjusted earnings of $3.38…
-
Walmart Shares Slip After Oppenheimer Downgrades Stock Ahead of Earnings
Walmart (NYSE:WMT) shares moved lower in U.S. pre-market trading after Oppenheimer downgraded the retail giant to “Perform” from “Outperform,” citing a less attractive near-term outlook ahead of the company’s earnings release on August 20. The brokerage also withdrew its previous $140 price target, and Walmart shares fell 1.4% by 08:22 ET (12:22 GMT). Oppenheimer Sees…
-
Cannabix Technologies Targets Combat Sports with Marijuana Breath Test
Cannabix Technologies (CSE:BLO) (USOTC:BLOZF) has taken another step in the commercialisation of its Marijuana Breath Test (MBT), announcing a strategic move into the combat sports market through its participation at the Association of Boxing Commissions (ABC) 38th Annual Conference. The development highlights the company’s growing focus on real-world deployment in safety-critical industries where rapid, objective…
-
IMAX Sets All-Time Monthly Box Office Record as The Odyssey Drives Historic Growth
IMAX Corporation (NYSE:IMAX) delivered the strongest month in its 50-plus-year history during July, generating $257 million in global box office revenue, a figure that exceeded its previous monthly record by 47%. Driving the historic performance was Christopher Nolan’s The Odyssey, which has already earned $221 million through IMAX theatres worldwide. The epic adventure remained a…
-
U.S. Trade Deficit Shrinks but Falls Slightly Short of Expectations
The U.S. trade deficit narrowed in the latest reporting period, although the improvement was slightly smaller than economists had anticipated. The latest figures showed the trade balance at -$73.30 billion, reflecting that the United States continued to import more goods and services than it exported. Deficit Misses Market Forecast Economists had expected the trade deficit…